CXCR4-directed antibodies suppressed lymph node metastasis in experimental breast cancer [10] and suppressed tumor growth and impaired the development of tumor endothelium in experimental models of colon and pancreatic cancer [39]. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.